Rival PBMs plan to take advantage over last month of Express Scripts-Medco uncertainty

The regulatory review of the Express Scripts-Medco merger now is in its final stages, and with the clock ticking down to that 30-day deadline, you can expect a full court-press from retail pharmacy interests looking to block the deal.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

© 2012 Drug Store News. All Rights Reserved.